Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About ProQR Therapeutics NV (PRQR) Anymore

Seeing as ProQR Therapeutics NV (NASDAQ:PRQR) has faced declining sentiment from hedge fund managers, it’s easy to see that there is a sect of hedgies that slashed their positions entirely in the third quarter. Interestingly, Malcolm Fairbairn’s Ascend Capital dumped the largest investment of the 700 funds followed by Insider Monkey, valued at close to $0.9 million in stock, and Jim Simons’ Renaissance Technologies was right behind this move, as the fund said goodbye to about $0.2 million worth of stock. These bearish behaviors are important to note, as total hedge fund interest dropped by 2 funds in the third quarter.

Let’s now take a look at hedge fund activity in other stocks similar to ProQR Therapeutics NV (NASDAQ:PRQR). We will take a look at Regulus Therapeutics Inc (NASDAQ:RGLS), First Defiance Financial (NASDAQ:FDEF), Versartic Inc (NASDAQ:VSAR), and Everi Holdings Inc (NYSE:EVRI). This group of stocks’ market values match PRQR’s market value.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
RGLS 13 46409 -1
FDEF 10 22421 1
VSAR 12 110250 2
EVRI 16 98144 -6

As you can see these stocks had an average of 13 hedge funds with bullish positions and the average amount invested in these stocks was $69 million. That figure was $86 million in PRQR’s case. Everi Holdings Inc (NYSE:EVRI) is the most popular stock in this table. On the other hand First Defiance Financial (NASDAQ:FDEF) is the least popular one with only 10 bullish hedge fund positions. ProQR Therapeutics NV (NASDAQ:PRQR) is not the most popular stock in this group, but hedge fund interest is still above average. This is a slightly positive signal, but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard EVRI might be a better candidate to consider a long position.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.